Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Bifunctional Metal-Organic Frameworks Integrate Energy- and Electron-Transfer Pathways for Enhanced Photodynamic Therapy.

Created on 13 Oct 2026

Authors

Zhibei Zhou, Yuxuan Xiong, Daqian Bian, Wenbin Lin

Published in

Angewandte Chemie (International ed. in English). Pages e7283158. Oct 12, 2026. Epub Oct 12, 2026.

Abstract

Metal-organic frameworks (MOFs) have emerged as promising nanophotosensitizers for photodynamic therapy (PDT), but most reported systems rely predominantly on a single O2-activation pathway, limiting their ability to produce complementary reactive oxygen species (ROS). Herein, we report a bifunctional MOF, Hf-VIO-DBP, that integrates porphyrinic photosensitizers (DBP) and viologen electron mediators (VIO2+) within a single framework to establish a dual-channel photoactive platform. The close spatial proximity of these two functional units enables efficient intra-framework electron transfer while preserving the energy transfer capability of the porphyrinic photosensitizers. Upon 630 nm irradiation, excited DBP transfers electrons to VIO2+ to generate viologen radical species, which mediate O2 reduction to generate type I ROS, including superoxide, hydrogen peroxide, and hydroxyl radicals. The resulting DBP radical cation is reduced by endogenous biomolecules such as 1,4-dihydronicotinamide adenine dinucleotide, thereby regenerating DBP and sustaining the photoredox cycle. Concurrently, energy transfer from excited DBP to O2 produces singlet oxygen through a type II pathway. Compared with the viologen-free MOF analogue, Hf-VIO-DBP markedly enhances type I ROS generation while retaining efficient type II ROS production, resulting in substantially improved overall ROS yields and phototoxicity. Therefore, Hf-VIO-DBP achieves potent PDT efficacy in CT26 and MC38 murine colon cancer models.

PMID:
42864967
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement